跳至主要内容
临床试验/NCT03544476
NCT03544476已完成不适用

Interactive Mobile Health Intervention to Support Patients With Active Tuberculosis

University of Washington2 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2019年4月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
42
试验地点
2
主要终点
Number of Participants With Treatment Success

研究概览

简要总结

The purpose of this study is to evaluate and further refine a mobile support tool for patients receiving treatment for active tuberculosis. Half of participants will receive support and monitoring using a mobile phone software application and usual care, while the other half will receive usual care.

详细描述

Tuberculosis (TB) remains a top ten leading cause of death globally despite it being a largely curable disease. New effective treatment supervision strategies are needed particularly in low-resource high TB burden settings and a potential solution is in the hands of nearly every patient - a mobile phone. Modern modular design mobile phone software applications ("apps") hold great promise to address this unmet need.

Current technologies allows for rapid design modification based on end user needs, implementation of native operating system (e.g., Android) versions for users with inconsistent internet access, and the integration of the patients' experiences with electronic health records using industry standards. Apps can perform multiple functions (e.g., automated reminders, symptom tracking, secure messaging, multi-media education). To date, few TB related apps have focused on patients as users, and none support patient engagement in self-management of their care or direct adherence monitoring. The research objectives are to understand end user needs and other stakeholder needs to build, refine, and pilot test an app to support patients self-administering treatment for active TB.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is starting TB treatment for the first time
  • Subject has no known TB drug resistance
  • Subject is HIV negative (self-reported or documented)
  • Subject owns or has regular access to a mobile phone that can access the Internet and is able to operate the mobile phone to communicate or have someone able to assist.

排除标准

  • Severely ill (i.e., requiring hospitalization)
  • Reside in the same household with another study participant
  • History of known drug resistance and HIV co-infection because their care is managed separately and the treatment regimens and duration differ.

结局指标

主要结局

Number of Participants With Treatment Success

时间窗: 6 months

Treatment outcomes will be measured using standard definitions set by the World Health Organization (WHO) Standards of TB treatment. Treatment success based on WHO definitions: completed (without bacteriological confirmation) or cured (negative sputum smear at 6 months and at least once prior to 6 months)). Other treatment outcomes include: failed (sputum smear positive at 5 months or later), died, defaulted (treatment interruption for ≥ 2 months), lost to follow-up (diagnosed, treatment outcome not documented), or transferred out (transferred to another reporting unit and treatment outcome is unknown).

次要结局

  • Engagement: Average Number of Days Participants Reported Through the App(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sarah Iribarren

Assistant Professor, Biobehavioral Nursing and Health Informatics

University of Washington

研究点 (2)

Loading locations...

相似试验